Instrument Inactif

Communiqués Orthocell Limited OTC Markets

Actions

ORHH.F

AU000000OCC6

Equipement et technologie médicale avancés

Communiqués

15/05/24	Orthocell reports 98.6% success rate in Striate+â„¢ dental membrane study	AQ
23/02/24	Orthocell raising $3.5 million; adds heavy hitters to register	AQ
01/11/23	Orthocell on the cusp of significant growth	AQ
29/05/23	Orthocell thrilled to welcome John Van Der Wielen as chairman	AQ
30/03/23	Orthocell welcomes globally recognised nerve surgeons to advisory board	AQ
08/03/23	Orthocell welcomes high profile US-based healthcare specialist to the board	AQ
21/04/22	Orthocell : Notification regarding unquoted securities - OCC	PU
30/12/21	Orthocell : Application for quotation of securities - OCC	PU
23/12/21	Orthocell : Application for quotation of securities - OCC	PU
16/12/21	Orthocell : Application for quotation of securities - OCC	PU
08/12/21	Orthocell : OrthoATI Tendon Clinical Study Success	PU
18/11/21	Orthocell : Application for quotation of securities - OCC	PU
09/11/21	Application for quotation of securities - OCC	PU
15/01/21	Orthocell : Receives US Market Clearance	BU
05/02/18	Orthocell : Positive Pre-Clinical Results Using CelGro® in Anterior Cruciate Ligament (ACL) Reconstruction	BU
18/01/18	Orthocell : Secures New Patent for Suture-Less Repair of Soft Tissue	BU
15/12/17	Orthocell : Granted European Tendon Regeneration Patent	BU
07/12/17	Orthocell : Commences Treatment of Its 1,000th Patient	BU
09/11/17	Orthocell : Receives CE Mark for CelGro®	BU
11/10/17	Orthocell : Appoints Surgical Specialties as Exclusive Distributor	BU
05/09/17	Orthocell : 1st Patient Recruited in Orthocell Ortho-ATI® Shoulder Tendon Study	BU
12/01/17	Orthocell : Announces Collaboration with Johnson & Johnson Innovation	BU
18/10/16	Orthocell : Receives Approval for Human Nerve Regeneration Study Using CelGro®	BU
03/03/16	Orthocell : Professor Rocky Tuan Appointed to Orthocell Advisory Board	BU
05/01/16	Orthocell : ‘Cell Factory’ Granted Patent in US	BU